Makale detayı · 2025
Is there a best JAK inhibitor in myelofibrosis when it comes to safety and anemia outcomes?
YÖKSİS
OpenAlex
SJR Q1
JCR Q2
Atıf 0
- Yıl
- 2025
- ISSN
1479-6694- Tür
- editorial
Veri kaynağı ayrımı
- YÖKSİS YÖKSİS makale kaydı
- OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)
Özet
İngilizce (OpenAlex)
1. Hepatosplenomegaly, bone marrow fibrosis, extramedullary hematopoiesis (EMH), hematopoietic stem cell proliferation, aberrant cytokine production, and constitutional symptoms are all linked to m...
Konular
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Vasculitis and related conditions
Birincil konu Myeloproliferative Neoplasms: Diagnosis and Treatment